Ventavis (Iloprost)

Iloprost is a medicine used to treat certain lung diseases like COPD. It helps open up the airways, making it easier to breathe. It's often given as an inhaler.

Brand names:Aurlumyn, Ventavis
Medication

What people taking Ventavis (Iloprost) report

Every report comes from a Lived member, sent anonymously.

Have you tried Ventavis (Iloprost) for Pulmonary Arterial Hypertension?

NameHow it went

About Ventavis (Iloprost)

What It's For

Iloprost is a prescription medicine that relaxes and widens blood vessels. In the US it has been sold in two very different forms for two unrelated conditions. Ventavis is an inhaled form approved for adults with pulmonary arterial hypertension (PAH), a rare disease in which the small arteries of the lungs narrow and stiffen, so the right side of the heart has to pump against high pressure. Ventavis was approved to improve exercise ability and symptoms and to lower the chance of the disease getting worse, and it was studied mainly in people whose breathlessness already limited ordinary activity. Inhaled iloprost has since been discontinued in the US, although it is still used in some other countries. Treprostinil (Tyvaso), another inhaled medicine that acts like prostacyclin, remains available in the US for PAH. Aurlumyn is an intravenous form of iloprost approved in 2024 as the first medicine for severe frostbite in adults, to reduce the risk of losing fingers or toes. Severe frostbite means the skin and the tissue beneath it have frozen and blood flow has stopped. Aurlumyn is given only in a hospital.

How It Works

Iloprost is a man-made version of prostacyclin, a substance the lining of blood vessels produces to keep them relaxed and to stop platelets (the blood cells that start clots) from clumping together. In PAH, breathing iloprost in delivers it straight to the lungs, where it widens the narrowed arteries. That lowers the pressure the heart pumps against, which can make walking and other exertion easier. The effect is brief: iloprost leaves the bloodstream within about an hour of an inhalation, which is why it has to be inhaled many times a day. Iloprost also makes platelets less sticky, but it is not known whether that adds to its benefit in PAH. In severe frostbite, the same two actions, opening blood vessels and discouraging clots, aim to restore blood flow to frozen fingers and toes before the tissue dies.

Dosage & Administration

Ventavis is inhaled through one specific nebulizer, the I-neb Adaptive Aerosol Delivery System, which measures each dose; other nebulizers may not deliver the right amount. Treatment starts at a lower dose and is raised if it is well tolerated. People inhale it 6 to 9 times a day while awake, no more often than every 2 hours. Because the benefit of a dose can fade before 2 hours pass, many people time a dose shortly before planned activity. Each session uses one fresh ampule, and any liquid left over is thrown away and the device cleaned. The solution should not be swallowed, mixed with other medicines in the nebulizer, or allowed to touch the skin or eyes, and other people, especially babies, should not breathe the mist. Keeping a backup nebulizer avoids missed doses if the device fails. It is supplied by a specialty pharmacy rather than a retail one. Aurlumyn is given by a hospital team as a slow drip into a vein over 6 hours each day, for up to 8 days in a row. The rate is based on body weight, starts low and is raised every 30 minutes as tolerated, with blood pressure and heart rate checked before the start and with each increase. People with significant liver or kidney disease may start at a lower rate.

Side Effects

With inhaled iloprost, the most common effects are flushing, a worse cough, headache, and a tight or aching jaw that can make it hard to open the mouth wide. Nausea, vomiting, trouble sleeping, tongue pain and a pounding heartbeat also occur. During an Aurlumyn infusion, headache, flushing, a fast or pounding heartbeat, nausea, vomiting, dizziness, jaw pain and muscle aches are common. Telling the nurse matters, because the team can slow the infusion until the symptoms settle. Both forms can lower blood pressure enough to cause dizziness or fainting. Standing up slowly from a bed or chair helps, and people should not drive or use machinery while dizziness or fainting is a problem. Fainting that keeps happening or gets worse should be reported to the prescriber: in PAH, fainting during exertion can also mean the disease is not well enough controlled and the dose or treatment needs to change. Bleeding, most often nosebleeds or coughing up small amounts of blood, has also been reported and is worth raising with the care team. Inhaled iloprost can make the muscles around the airways tighten, especially in people with sensitive airways such as those with asthma. Sudden trouble breathing, wheezing or gasping, coughing up pink, frothy mucus, or bluish lips or skin after using it needs emergency help right away: stop the medicine and call 911.

Interactions & Warnings

Because iloprost makes platelets less sticky, bleeding is more likely when it is combined with blood thinners such as warfarin or with antiplatelet medicines such as aspirin. The prescriber should know about every medicine and supplement that affects clotting. Blood pressure medicines and other drugs that widen blood vessels can add to iloprost's lowering of blood pressure. Inhaled iloprost should not be started when the top (systolic) blood pressure number, the pressure as the heart beats, is below 85 mmHg. Before an Aurlumyn infusion, the hospital team corrects low blood pressure and may pause other blood pressure medicines while it runs. Inhaled iloprost has not been tested in people with chronic obstructive pulmonary disease (COPD), severe asthma or a current lung infection, so these conditions should be discussed before starting. In a less common type of pulmonary hypertension caused by problems in the veins draining the lungs, iloprost can lead to fluid building up in the lungs, and treatment is stopped if that happens. Ventavis was not studied in children. Breastfeeding is not advised during treatment. Information on iloprost in pregnancy is limited, while PAH itself is very dangerous in pregnancy, raising the risk of heart failure, stroke and death for the mother and of miscarriage, preterm birth and stillbirth. Anyone with PAH who is pregnant or planning a pregnancy needs early planning with a pulmonary hypertension specialist.

What to Expect

For PAH, inhaled iloprost was usually added to other treatments. In the main 12-week trial, about 1 in 5 people with PAH on iloprost met a combined measure of response (walking at least 10% farther in six minutes, moving up at least one symptom class, and no worsening of the disease), compared with about 1 in 25 on placebo. On average, people walked about 40 meters farther than with placebo when tested 30 minutes after a dose, with a smaller gain just before the next one. Iloprost controls PAH but does not cure it, so treatment continues long term and should not be stopped without the specialist team. Regular follow-up checks symptoms, walking ability and blood pressure. Six to nine sessions a day, each with preparation and cleaning, is a real commitment that is worth weighing against other options. For severe frostbite, Aurlumyn is a short hospital course alongside rewarming and wound care, and treatment begins as soon as the team judges it suitable. In the small study behind its approval, everyone also received aspirin and standard care. None of 16 people given iloprost alone had a bone scan at day 7 that predicted losing a finger or toe, compared with 9 of 15 people who did not get iloprost, and later amputations matched the scans. The study was open-label (everyone knew which treatment they received) and involved young, healthy adults injured at high altitude, so how well the results apply to other people is less certain. The American Burn Association's 2023 guideline did not make a recommendation for or against iloprost.

Questions to Ask Your Doctor

  1. 1.Since inhaled iloprost is no longer sold in the US, which prostacyclin-type treatment would suit my PAH, and how does its daily routine compare?
  2. 2.How will we judge whether iloprost is helping, and which tests will we use to follow my PAH?
  3. 3.Is my blood pressure high enough for this medicine, and what should I do if I feel dizzy or faint?
  4. 4.Do my blood thinners, aspirin or blood pressure medicines need to change while I take iloprost?
  5. 5.For frostbite, am I a candidate for Aurlumyn or for other treatments such as clot-dissolving medicine, and how will we know whether my fingers or toes can be saved?

Last reviewed • Oct 2026

Educational content, not medical advice.